...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Transfer of ZEN from RBC DI to TFSA
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Here is a question for the board, the current MV is .63cents USD  and has been that way for now quite sometime and the latest Zenith PP was $2 USd and we have moved well into end of phase 2 with release of trial data coming up i assume,  

Why then is the MV currently at .63uSd and not the $2usd that the PP have been the last one.  This bodes well for those transfering to registered accounts and if there is a buyout then even better for shareholders....

 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply